DRESS Syndrome Associated with Liposomal Amphotericin-B in a Kidney Transplant Patient : A Case Report
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
INTRODUCTION: Liposomal amphotericin B is a widely used broad-spectrum antifungal drug. It was developed to reduce nephrotoxicity and maximize the therapeutic utility of amphotericin B in the treatment of invasive fungal infections. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe drug-induced hypersensitivity syndrome commonly associated with aromatic antiepileptic drugs. Liposomal amphotericin-B was associated with DRESS syndrome in only one case.
CASE REPORT: We report an exceptional case of possible DRESS syndrome associated with liposomal amphotericin B in a 31-year-old male renal transplant recipient. Seventeen days after starting liposomal amphotericin B for visceral leishmaniosis, he developed a skin rash with elevated liver tests. Liposomal amphotericin B was then discontinued. A favourable outcome was slowly observed in one month.
RESULTS AND CONCLUSION: This case scored two (possible case) based on the criteria adopted by the European group RegiSCAR. The Naranjo score for liposomal amphotericin B was four (possible).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Current drug safety - 18(2023), 2 vom: 25., Seite 264-266 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Charfi, Ons [VerfasserIn] |
---|
Links: |
---|
Themen: |
7XU7A7DROE |
---|
Anmerkungen: |
Date Completed 09.03.2023 Date Revised 09.03.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1574886316666210727145646 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328600865 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328600865 | ||
003 | DE-627 | ||
005 | 20231225203301.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1574886316666210727145646 |2 doi | |
028 | 5 | 2 | |a pubmed24n1095.xml |
035 | |a (DE-627)NLM328600865 | ||
035 | |a (NLM)34315381 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Charfi, Ons |e verfasserin |4 aut | |
245 | 1 | 0 | |a DRESS Syndrome Associated with Liposomal Amphotericin-B in a Kidney Transplant Patient |b A Case Report |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 09.03.2023 | ||
500 | |a Date Revised 09.03.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a INTRODUCTION: Liposomal amphotericin B is a widely used broad-spectrum antifungal drug. It was developed to reduce nephrotoxicity and maximize the therapeutic utility of amphotericin B in the treatment of invasive fungal infections. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe drug-induced hypersensitivity syndrome commonly associated with aromatic antiepileptic drugs. Liposomal amphotericin-B was associated with DRESS syndrome in only one case | ||
520 | |a CASE REPORT: We report an exceptional case of possible DRESS syndrome associated with liposomal amphotericin B in a 31-year-old male renal transplant recipient. Seventeen days after starting liposomal amphotericin B for visceral leishmaniosis, he developed a skin rash with elevated liver tests. Liposomal amphotericin B was then discontinued. A favourable outcome was slowly observed in one month | ||
520 | |a RESULTS AND CONCLUSION: This case scored two (possible case) based on the criteria adopted by the European group RegiSCAR. The Naranjo score for liposomal amphotericin B was four (possible) | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a DRESS syndrome | |
650 | 4 | |a Leishmaniosis | |
650 | 4 | |a adverse drug reaction | |
650 | 4 | |a amphotericin | |
650 | 4 | |a drug hypersensitivity syndrome | |
650 | 4 | |a pharmacovigilance | |
650 | 7 | |a liposomal amphotericin B |2 NLM | |
650 | 7 | |a Amphotericin B |2 NLM | |
650 | 7 | |a 7XU7A7DROE |2 NLM | |
650 | 7 | |a Antifungal Agents |2 NLM | |
700 | 1 | |a Hammamia, Syrine Ben |e verfasserin |4 aut | |
700 | 1 | |a Aouinti, Imen |e verfasserin |4 aut | |
700 | 1 | |a Kaabi, Widd |e verfasserin |4 aut | |
700 | 1 | |a Kastalli, Sarrah |e verfasserin |4 aut | |
700 | 1 | |a Daghfous, Riadh |e verfasserin |4 aut | |
700 | 1 | |a El Aidli, Sihem |e verfasserin |4 aut | |
700 | 1 | |a Lakhoua, Ghozlane |e verfasserin |4 aut | |
700 | 1 | |a Zaiem, Ahmed |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 18(2023), 2 vom: 25., Seite 264-266 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2023 |g number:2 |g day:25 |g pages:264-266 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886316666210727145646 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2023 |e 2 |b 25 |h 264-266 |